Harris PE - Search Results

1

The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours.

Harris PE, Afshar F, Coates P, Doniach I, Wass JA, Besser GM, Grossman A. Harris PE, et al. Q J Med. 1989 May;71(265):417-27. Q J Med. 1989. PMID: 2602541

2

Successful treatment by chemotherapy for acromegaly associated with ectopic growth hormone releasing hormone secretion from a carcinoid tumour.

Harris PE, Bouloux PM, Wass JA, Besser GM. Harris PE, et al. Clin Endocrinol (Oxf). 1990 Mar;32(3):315-21. doi: 10.1111/j.1365-2265.1990.tb00872.x. Clin Endocrinol (Oxf). 1990. PMID: 2111746

3

Immunoreactive human chorionic gonadotrophin from the cyst fluid and CSF of patients with craniopharyngioma.

Harris PE, Perry L, Chard T, Chaudry L, Cooke BA, Touzel R, Coates P, Lowe DG, Afshar F, Wass JA, et al. Harris PE, et al. Clin Endocrinol (Oxf). 1988 Nov;29(5):503-8. doi: 10.1111/j.1365-2265.1988.tb03699.x. Clin Endocrinol (Oxf). 1988. PMID: 2472911

4

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.

Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA, McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA, Wardlaw JM. Bevan JS, et al. Among authors: harris pe. J Clin Endocrinol Metab. 2002 Oct;87(10):4554-63. doi: 10.1210/jc.2001-012012. J Clin Endocrinol Metab. 2002. PMID: 12364434 Clinical Trial.

5

Biochemical markers for clinically non-functioning pituitary tumours.

Harris PE. Harris PE. Clin Endocrinol (Oxf). 1998 Aug;49(2):163-4. doi: 10.1046/j.1365-2265.1998.00539.x. Clin Endocrinol (Oxf). 1998. PMID: 9828901 No abstract available.

6

The treatment of de novo acromegalic patients with octreotide-LAR: efficacy, tolerability and cardiovascular effects.

Gilbert J, Ketchen M, Kane P, Mason T, Baister E, Monaghan M, Barr S, Harris PE. Gilbert J, et al. Among authors: harris pe. Pituitary. 2003;6(1):11-8. doi: 10.1023/a:1026273509058. Pituitary. 2003. PMID: 14674719 Clinical Trial.

7

Mutation analysis of protein kinase A catalytic subunit in thyroid adenomas and pituitary tumours.

Esapa CT, Harris PE. Esapa CT, et al. Among authors: harris pe. Eur J Endocrinol. 1999 Oct;141(4):409-12. doi: 10.1530/eje.0.1410409. Eur J Endocrinol. 1999. PMID: 10526256

8

Gs protein mutations and the pathogenesis and function of pituitary tumors.

Harris PE. Harris PE. Metabolism. 1996 Aug;45(8 Suppl 1):120-2. doi: 10.1016/s0026-0495(96)90104-3. Metabolism. 1996. PMID: 8769404 Review.

9

The GnRH test in the assessment of patients with pituitary and parapituitary lesions: results of a 5-year retrospective study.

Chammas NK, Chambers SM, Harris PE. Chammas NK, et al. Among authors: harris pe. Pituitary. 2008;11(3):271-8. doi: 10.1007/s11102-008-0124-4. Pituitary. 2008. PMID: 18425583

10

Prevalence of Ras mutations in thyroid neoplasia.

Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW, Harris PE. Esapa CT, et al. Among authors: harris pe. Clin Endocrinol (Oxf). 1999 Apr;50(4):529-35. doi: 10.1046/j.1365-2265.1999.00704.x. Clin Endocrinol (Oxf). 1999. PMID: 10468914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters